Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growthSYFOVRE® (pegcetacoplan injection) full year 2024 net ...

Expect initiation of a Phase 2 multi-dose study of APL-3007 + SYFOVRE in 2Q 2025 ... Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment ...

APL-3007 (siRNA) + SYFOVRE Expect initiation ... Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

Broncos players have recounted the magical 55m try that lasted 23 seconds, and featured eight players and 11 passes against an ordinary-looking Roosters side.

In the remote village of Badhal, Jammu and Kashmir, a mysterious illness has claimed 17 lives, including 13 children, over a two-month period. Despite forensic confirmation of neurotoxic exposure, ...

The following is a summary of “Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality,” published ...

Extensive clinical studies of oral-ATO have demonstrated its high efficacy and safety in curing APL patients, with an overall survival (OS) rate exceeding 97%, along with a significant reduction ...

Axis Securities suggested a 'Buy' and a target of Rs 710. On APL Apollo Tubes, it sees Ebitda per tonne rebounding, as demand normalises. The brokerage suggested a target of Rs 1,750. For Tata ...